Rare diseases
Investigational molecules
Locations
Back to Portugal673 clinical trials in Almada, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Safety and Effects of EIK1004 for Patients with Advanced Solid Tumors
PortugalStudy of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
PortugalComparison of Low-Dose Exemestane versus Low-Dose Tamoxifen for Breast Cancer Prevention in Postmenopausal Women at High Risk
PortugalStudy of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy
PortugalStudy on the Effectiveness and Safety of Pirtobrutinib and Rituximab for Untreated Adult Patients with Indolent Mantle Cell Lymphoma
PortugalStudy of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis
PortugalStudy on the Effects of Faricimab for Caucasian Patients with Polypoidal Choroidal Vasculopathy
PortugalStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
PortugalStudy on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy
PortugalStudy on the Safety and Effects of DNL593 for Patients with Frontotemporal Dementia
PortugalStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
PortugalStudy on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17
PortugalThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary arterial hypertension and chronic obstructive pulmonary disease, evaluating novel treatments including ralinepag and itepekimab for long-term management of these conditions.
Research investigating treatments for systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, with studies on medications like upadacitinib and remibrutinib.
Studies examining treatments for multiple sclerosis, migraine prevention, and neurological conditions, testing medications such as ocrelizumab and atogepant.
Investigations into hypertrophic cardiomyopathy and stroke prevention, studying treatments like mavacamten and asundexian for improved cardiac outcomes.
Advanced studies in lung cancer, colorectal cancer, and head and neck cancers, evaluating novel immunotherapy combinations and targeted treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
